全文获取类型
收费全文 | 35263篇 |
免费 | 1358篇 |
国内免费 | 89篇 |
专业分类
耳鼻咽喉 | 134篇 |
儿科学 | 2165篇 |
妇产科学 | 879篇 |
基础医学 | 2358篇 |
口腔科学 | 527篇 |
临床医学 | 2442篇 |
内科学 | 7172篇 |
皮肤病学 | 341篇 |
神经病学 | 1298篇 |
特种医学 | 876篇 |
外科学 | 5466篇 |
综合类 | 3937篇 |
预防医学 | 5944篇 |
眼科学 | 484篇 |
药学 | 1646篇 |
9篇 | |
中国医学 | 311篇 |
肿瘤学 | 721篇 |
出版年
2023年 | 248篇 |
2022年 | 502篇 |
2021年 | 868篇 |
2020年 | 687篇 |
2019年 | 3752篇 |
2018年 | 2974篇 |
2017年 | 1489篇 |
2016年 | 501篇 |
2015年 | 571篇 |
2014年 | 1573篇 |
2013年 | 1240篇 |
2012年 | 1282篇 |
2011年 | 1269篇 |
2010年 | 1078篇 |
2009年 | 930篇 |
2008年 | 801篇 |
2007年 | 786篇 |
2006年 | 590篇 |
2005年 | 541篇 |
2004年 | 451篇 |
2003年 | 384篇 |
2002年 | 265篇 |
2001年 | 236篇 |
2000年 | 181篇 |
1999年 | 170篇 |
1998年 | 151篇 |
1997年 | 162篇 |
1996年 | 89篇 |
1995年 | 65篇 |
1994年 | 60篇 |
1993年 | 39篇 |
1992年 | 29篇 |
1991年 | 33篇 |
1990年 | 24篇 |
1989年 | 29篇 |
1988年 | 25篇 |
1987年 | 10篇 |
1985年 | 984篇 |
1984年 | 1418篇 |
1983年 | 1061篇 |
1982年 | 1160篇 |
1981年 | 1105篇 |
1980年 | 971篇 |
1979年 | 1063篇 |
1978年 | 997篇 |
1977年 | 695篇 |
1976年 | 892篇 |
1975年 | 793篇 |
1974年 | 708篇 |
1973年 | 744篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Saudi Pharmaceutical Journal》2022,30(11):1572-1588
Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of a metabolic syndrome caused by excessive accumulation of fat in the liver. Orthosiphon stamineus also known as Orthosiphon aristatus is a medicinal plant with possible potential beneficial effects on various metabolic disorders. This study aims to investigate the in vitro inhibitory effects of O. stamineus on hepatic fat accumulation and to further use the computational systems pharmacology approach to identify the pharmacokinetic properties of the bioactive compounds of O. stamineus and to predict their molecular mechanisms against NAFLD. Methods: The effects of an ethanolic extract of O. stamineus leaves on cytotoxicity, fat accumulation and antioxidant activity were assessed using HepG2 cells. The bioactive compounds of O. stamineus were identified using LC/MS and two bioinformatics databases, namely the Traditional Chinese Medicine Integrated Database (TCMID) and the Bioinformatics Analysis Tool for the Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). Pathway enrichment analysis was performed on the predicted targets of the bioactive compounds to provide a systematic overview of the molecular mechanism of action, while molecular docking was used to validate the predicted targets. Results: A total of 27 bioactive compounds corresponding to 50 potential NAFLD-related targets were identified. O. stamineus exerts its anti-NAFLD effects by modulating a variety of cellular processes, including oxidative stress, mitochondrial β-oxidation, inflammatory signalling pathways, insulin signalling, and fatty acid homeostasis pathways. O. stamineus is significantly targeting many oxidative stress regulators, including JNK, mammalian target of rapamycin (mTOR), NFKB1, PPAR, and AKT1. Molecular docking analysis confirmed the expected high affinity for the potential targets, while the in vitro assay indicates the ability of O. stamineus to inhibit hepatic fat accumulation. Conclusion: Using the computational systems pharmacology approach, the potentially beneficial effect of O. stamineus in NAFLD was indicated through the combination of multiple compounds, multiple targets, and multicellular components. 相似文献
2.
目的 鉴定当地民间应用普遍的野生药用真菌,并探讨其治疗肿瘤的作用机制。方法 采用形态学和分子生物学方法对一株采自定陶仿山野生药用真菌进行鉴定,确定为硬皮马勃。通过文献检索收集硬皮马勃化学成分,利用PubChem软件和TCMSP、GCS数据库得到化学成分结构信息及其药用动力学参数和相关靶点分析,通过SysDT和WES系统鉴定潜在化学成分靶点,利用CTD数据库获得靶点功能,将潜在化合物和肿瘤相关靶点导入Cytoscape3.8.0软件构建分子-靶标网络。应用DAVID数据库对肿瘤相关靶点进行GO和KEGG富集分析,揭示有关活性成分靶点所涉及的生物学过程和通路,将肿瘤相关靶点和通路导入Cytoscape3.8.0软件构建靶点-通路网络。结果 从文献中获得硬皮马勃的化学成分59个,通过ADME计算系统筛选出5个潜在活性的化合物即活性成分,预测到38个靶点,其中与肿瘤相关靶点16个。这些活性成分主要通过Toll-like receptor、PI3K-AKT、MAPK和NF-kappa B等通路参与免疫应答,抑制肿瘤细胞生长、增殖,促进其凋亡。结论 表明硬皮马勃治疗肿瘤具有多靶点、多途径协同作用的特点,并通过多层次效应达到治疗肿瘤的效果。本研究为更好理解硬皮马勃作用肿瘤的机制和肿瘤药物开发提供理论依据。 相似文献
3.
《Vaccine》2022,40(7):1001-1009
Vaccination guidelines for dogs and cats indicate that core vaccines (for dogs, rabies, distemper, adenovirus, parvovirus; for cats, feline parvovirus, herpes virus-1, calicivirus) are essential to maintain health, and that non-core vaccines be administered according to a clinician’s assessment of a pet’s risk of exposure and susceptibility to infection. A reliance on individual risk assessment introduces the potential for between-practice inconsistencies in non-core vaccine recommendations. A study was initiated to determine non-core vaccination rates of dogs (Leptospira, Borrelia burgdorferi, Bordetella bronchiseptica, canine influenza virus) and cats (feline leukemia virus) in patients current for core vaccines in veterinary practices across the United States. Transactional data for 5,531,866 dogs (1,670 practices) and 1,914,373 cats (1,661 practices) were retrieved from practice management systems for the period November 1, 2016 through January 1, 2020, deidentified and normalized. Non-core vaccination status was evaluated in 2,798,875 dogs and 788,772 cats that were core-vaccine current. Nationally, median clinic vaccination rates for dogs were highest for leptospirosis (70.5%) and B. bronchiseptica (68.7%), and much lower for canine influenza (4.8%). In Lyme-endemic states, the median clinic borreliosis vaccination rate was 51.8%. Feline leukemia median clinic vaccination rates were low for adult cats (34.6%) and for kittens and 1-year old cats (36.8%). Individual clinic vaccination rates ranged from 0 to 100% for leptospirosis, B. bronchiseptica and feline leukemia, 0–96% for canine influenza, and 0–94% for borreliosis. Wide variation in non-core vaccination rates between clinics in similar geographies indicates that factors other than disease risk are driving the use of non-core vaccines in pet dogs and cats, highlighting a need for veterinary practices to address gaps in patient protection. Failure to implement effective non-core vaccination strategies leaves susceptible dogs and cats unprotected against vaccine-preventable diseases. 相似文献
4.
Tonya J.H. White 《Journal of the American Academy of Child and Adolescent Psychiatry》2019,58(11):1042-1050
5.
6.
7.
8.
9.
10.